Background: Centromere protein H (CENP-H) is one of the fundamental components of the human active kinetochore. Recently, CENP-H was identified to be associated with tumorigenesis. This study was aimed to investigate the clinicopathologic significance of CENP-H in tongue cancer.
Background
The kinetochore is a large protein complex assembled on centromere DNA and kinetochore dysfunction is an important source for chromosome instability [1, 2] . More than 60 kinetochore proteins have been identified in yeast in recent years [3] [4] [5] . Multiple kinetochore proteins have been shown to be deregulated in human cancers, which suggests an important role of kinetochore for chromosome instability and cancer development [6] [7] [8] [9] .
CENP-H was initially identified in the mouse centromere as a fundamental component of the active centromere [10, 11] . Human CENP-H presented at the inner plate of kinetochore throughout the cell cycle, co-localized with CENP-A and CENP-C, and was necessary for the appropriate localization of CENP-C [10] [11] [12] [13] . Recent report demonstrated that the CENP-H-I complex was required for the efficient incorporation of newly synthesized CENP-A into centromere [14] . These findings indicate that CENP-H might play an essential role in kinetochore assembly and function throughout the cell cycle. CENP-H is also strongly correlated with human cancer. It's expression was deregulated in colorectal cancers, and ectopic overexpression of CENP-H induces chromosome instability in diploid cell lines [6] . In addition, CENP-H was deregulated in oral squamous cell carcinomas (SCCs), nasopharyngeal carcinoma (NPC), and esophageal carcinoma [15] [16] [17] . The expression of CENP-H might be a valuable prognostic marker which could predict the early stage NPC [15] . Further more, the expression of CENP-H in oral SCCs was significantly correlated with the cell proliferation in malignant conditions [17] .
Genomic aberrations including aneuploidy in epithelial cells of the oral mucosa indicate high risks of oral cancer and cancer-related mortality [18] . Tongue cancer is one of the most common and serious types of oral cancer with poor prognosis [19, 20] . It is of great clinical value to identify efficient proliferation markers and valuable markers that help to find tongue cancer patients at very early stage. In this study, we investigated the expression of CENP-H in tongue cancer and evaluated the role of CENP-H in proliferation of tongue cancer cells.
Methods

Cell cultures
Primary cultured normal tongue mucosa epithelial cells (TEC) were maintained in Keratinocyte-SFM (Gibco, Invitrogen Corp, USA). Tongue cancer cell lines TSCCa and Tca8113 were cultured in RPMI 1640 medium supplemented with 10% fetal calf serum (HyClone, Logan, UT).
Vectors and retroviral infection
Silence endogenous CENP-H, RNAi oligonucleotides (5-GGATCCTGCCCTTAAGGAAAT-3) was cloned into the pSuper-retro-puro vector to generate pSuper-retro-CENP-H-siRNA. Retroviral production and infection were performed as described previously [21] . Stable Tca8113 cells expressing CENP-H RNAi were selected for 10 days with
CENP-H expression was tested in normal tongue cell line and tongue cancer cell lines classified according to the current International Union Against Cancer (UICC) tumor-node-metastasis (TNM) classification [22, 23] .
RT-PCR and real-time RT-PCR
RT-PCR and real-time RT-PCR analysis were performed as described previously [24] . The primers and probes for RT-PCR and the real-time RT-PCR were designed with Primer Express v 2.0 (Applied Biosystems, Inc.) and provided in Table 1 .
Western blot
Western blot analysis was performed as described previously [15, 24] using anti-CENP-H (Bethyl Laboratories, Montgomery, Texas, USA), anti-α-Tubulin (Sigma, Saint Louis, Michigan, USA), anti-p21, anti-p27 and anti-Rb antibodies (Cell Signaling, Danvers, Massachusetts, USA).
Immunohistochemical analysis
The staining procedures and result measure of CENP-H were done as described previously [15, 24] . The cells at each intensity of staining were recorded on a scale of 0 (no staining), 1 (weak staining = light yellow), 2 (moderate staining = yellowish brown), and 3 (strong staining = brown). An intensity score of ≥ 2 with at least 50% of malignant cells with positive CENP-H staining was used to classify tumors with high expression, and < 50% of malignant cells with nuclear staining or < 2 intensity score classified tumors with low expression of CENP-H.
MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assay
Growing cells (5 × 103 per well) were seeded into 96-well plates. Cells were stained with 100 μl sterile MTT dye (0.5 mg/ml, Sigma, St. Louis, Missouri, USA) at each time point, followed by additional incubation for 4 h at 37°C. After removal of the culture medium from each well, 150
μl of dimethyl sulphoxide (Sigma, St. Louis, MO, USA) was added and thoroughly mixed for 15 min. The optical density was read at 570 nm using a microplate reader (Bio-Rad 3500, Hercules, California, USA), with 655 nm as the reference wavelength. All experiments were performed in triplicate.
Colony formation assays
Cells were seeded in 6-well plates (1×103 cells per well) and cultured for two weeks. The colonies were fixed with methanol for 10 min and stained with 1% crystal violet for 1 min. Each group of cells was performed in triplicate.
Bromodeoxyuridine (BrdU) incorporation and immunofluorescence
Cells grown on cover slips (Fisher, Pittsburgh, Pennsylvania, USA) were synchronized by serum starvation (0.5%FBS) for 48 h and then released into serum-containing medium for 4 h. The cells were labelled by incubating in 10-μM bromodeoxyuridine (BrdU) for 1 hour, fixed with 4% paraformaldehyde and stained with anti-BrdUrd antibody (Upstate, Temecula, California, USA). The cover slips were imaged with a con-focal laser-scanning microscope (Axiovert 200 M, Zeiss). At least 500 nuclei were count to determine the proportion of positive nuclei (BrdU index). All values presented are the means of at least three independent experiments.
Statistical analysis
All statistical analyses were performed using the SPSS 13.0 statistical software package. The Mann-Whitney U test and Spearman's correlation coefficient by log-rank test were used to assess the relationship between CENP-H expression and clinicopathologic parameters. Overall survival curves were plotted by the Kaplan-Meier method and were compared by the log-rank test. The Cox proportional hazards regression model was used for multivariate analysis. 
Results
CENP-H expression is elevated in human tongue cancer cells and primary tongue cancers
Western blot analyses on normal tongue mucosa epithelial cells (TEC) and two tongue cancer cell lines (TSCCa and Tca8113) revealed that CENP-H protein was highly expressed in cancer cells, while it was only weakly detected in TEC cells ( Figure 1A) . The RT-PCR results displayed a higher expression of CENP-H mRNA in cancer cell lines than that in normal tongue cells ( Figure 1B ). Real-time RT-PCR results showed higher level of CENP-H mRNA in comparison with TEC cells, increasing up to 15-fold in both tongue cancer cell lines ( Figure 1C ). In addition, both CENP-H protein and mRNA were overexpressed in all six cases of tongue cancer biopsies compared with that in the matched adjacent noncancerous tissues (Figure 2A and 2B) . The quantitative PCR showed that the CENP-H protein expression in paraffin-embedded tongue cancer tissue samples and its prognostic value tumor/normal (T/N) ratio of CENP-H mRNA levels were diversity from approximately 4 to 20-fold ( Figure 2C ). immunohistochemical analysis further confirmed this result ( Figure 2D ). These observations suggested that high CENP-H expression was associated with the clinical progression of tongue cancer.
Clinicopathological significance of CENP-H in human tongue cancer tissues
55.95% (94/168) of the samples were highly detected by the rabbit-human CENP-H polyclonal antibody ( Figure  3A ). Signals were mainly observed in the cancerous areas, and no or only weak signals were detected in the normal tissues ( Figure 3A ). Additional file 1 shows that the immunohistochemical staining signal with CENP-H antibody could be completely blocked by recombinant CENP-H polypeptide. This result indicated that the CENP-H antibody used in the present study specifically recognizes the CENP-H protein.
Mann-Whitney U test showed that CENP-H expression was strongly correlated with clinical stage (P = 0.005) and T classification (P = 0.004). While no significant association was found between CENP-H level and lymph node metastasis (P = 0.172) ( Table 2 ). There were also no significant correlations between the CENP-H expression level and age or gender (data not shown). Kaplan-Meier survival analysis showed a better outcome for patients who with low CENP-H level ( Figure 3B, upper panel) . The median survival period for patients with high CENP-H expression levels was substantially shorter (53 months) than that for patients with low CENP-H expression levels (76 months) (P = 0.0006, log-rank test). Multivariate Cox regression analysis revealed that the relationship between CENP-H expression and overall survival remained unchanged even when adjustments were made for tumor stage (Table 3 ). Additionally, CENP-H expression and overall survival were significantly correlated in stage I (n = 38, P = 0.0033) and stage II (n = 41, P = 0.0117) subgroups of patients ( Figure 3B, lower panel) . However, no such correlation was observed with regard to a subgroup of patients with stage III (data not shown). These results suggest that CENP-H can predict the prognosis of tongue cancer in patients only in the early stage of the disease.
Downregulation of CENP-H inhibits proliferation of Tca8113 cells
The impact of CENP-H expression on tongue cancer proliferation was evaluated in CENP-H knockdown cells (Figure 4) . As shown in Figure 4A , the depletion of CENP-H expression caused significantly compromised viability in These results suggested that CENP-H is essential for the proliferation of Tca8113 cells in vitro.
CENP-H regulates Survivin expression in tongue cancer cells
As deregulation of the CENP-H expression firmly linked with proliferation of tongue cancer cells, we further investigated the modulate cell cycle factors which could be regulated by CENP-H. Western blot analysis revealed that the expression level of Survivin in CENP-H knockdown cells was significantly downregulated as compared with control cells ( Figure 4C ).
Discussion
Defects in kinetochore function are responsible for chromosome instability and the generation of cancer. Several kinetochore proteins have been shown to be deregulated in human oral SCCs. CENP-F and Survivin expression were elevated in oral SCCs [25] . CENP-H was upregulated in human oral SCCs and CENP-H mRNA expression level was significantly correlated with the clinical stage of this disease. Higher CENP-H mRNA level predicted poor prognosis of oral SCC patients [17] . In the present study, we found that CENP-H was upregulated in oral tongue cancer cells and tongue cancer tissue samples both at transcriptional levels and at translational levels, indicating that CENP-H might play a crucial role in the human tongue cancer. We also found that CENP-H level was positively correlated with the clinical stage and T classification. These results indicate the possible role of CENP-H in progression of oral tongue cancer. Furthermore, we found that CENP-H expression was a significant predictor of poor prognosis for a subgroup of patients with early-stage cancer according to the clinical stage. Together with our results, CENP-H may be a new biomarker of early-stage tongue cancer.
Recently, several studies have documented that deregulation of kinetochore proteins frequently occur in cancer development and progression [6, [14] [15] [16] [17] [26] [27] [28] . Shigeishi et al. reported that CENP-H was derugulated in oral SCCs and closely linked to the increased or abnormal cell proliferation in malignant conditions [17] . Since our results showed that CENP-H was deregulated in tongue cancer, we consider whether change of CENP-H expression level can affect the growth of tongue cancer cells. In fact, we found that downregulation of CENP-H significantly inhibits the proliferation of tongue cancer cells.
We further investigated the potential mechanism by which CENP-H inhibits the proliferation rate of tongue cancer cells (Tca8113). We found that the expression level of Survivin in CENP-H-kncokdown Tca8113 cells was significantly downregulated as compared with control cells.
As an essential chromosome passenger protein, Survivin exhibits a dynamic interaction with centromeres, concentrated at the inner centromere at metaphase [29] . Survivin also belongs to the inhibitor of apoptosis protein family and functions as an essential regulator of cell division and apoptosis, and it ensuring continued cell proliferation and cell survival in unfavorable milieus [30] [31] [32] . Survivin is overexpressed in most oral SCCs and its high expression can predict poor prognosis of oral SCCs patients [33] . Additionally, expression of Survivin is an early event during oral carcinogenesis [34] . In the present study, we found that depletion of CENP-H can downregulate the expression of Survivin protein. Thus, the clinical and biological significance of CENP-H and Survivin oral cancer including tongue cancer suggested that both deregulation of Survivin and CENP-H were early event in development of this kind of cancer.
In summary, the present study not only demonstrated the possible role of CENP-H in the development and progression of tongue cancer, but also suggested the possibility of using CENP-H as a prognostic indicator for tongue cancer patients within early stage. To our knowledge, this is the first report showing that ectopic expression of CENP-H could significantly enhance proliferation of tongue cancer cells though upregulation of Survivin expression. However, the molecular mechanisms by which CENP-H upregulate Survivin expression need to be investigated in future.
Conclusion
In conclusion, expression of CENP-H was associated with clinical stage and T classification of tongue cancer, as well as poor prognosis of tongue cancer patients. Down-regulation of CENP-H can inhibit the proliferation of tongue cancer cells. These findings suggested that CENP-H play an important role in development and progression of tongue cancer. It also might be a valuable prognostic biomarker for early stage tongue cancer patients.
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